Trial Profile
Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Pulmonary embolism; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- 16 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.